Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost.
作者信息
Cao Davide, Dangas George, Mehran Roxana
机构信息
The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York NY.
出版信息
J Am Heart Assoc. 2021 Feb 16;10(4):e019889. doi: 10.1161/JAHA.120.019889. Epub 2021 Feb 9.
Abstract
摘要
相似文献
1
Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost.长期使用替格瑞洛治疗既往心肌梗死的稳定型患者：首要的是避免出血。
J Am Heart Assoc. 2021 Feb 16;10(4):e019889. doi: 10.1161/JAHA.120.019889. Epub 2021 Feb 9.
2
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.替格瑞洛在稳定型冠心病合并糖尿病患者中的应用。
N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1.
3
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).替格瑞洛治疗心肌梗死后患者预防中风：PEGASUS-TIMI 54 研究的见解（在阿司匹林-溶栓治疗心肌梗死 54 研究背景下，与安慰剂相比，替格瑞洛用于既往心肌梗死患者预防心血管事件的疗效）。
Circulation. 2016 Sep 20;134(12):861-71. doi: 10.1161/CIRCULATIONAHA.116.024637. Epub 2016 Aug 30.
4
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.替格瑞洛联合或不联合阿司匹林用于 PCI 术后高危患者。
N Engl J Med. 2019 Nov 21;381(21):2032-2042. doi: 10.1056/NEJMoa1908419. Epub 2019 Sep 26.
5
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.替格瑞洛用于外周动脉疾病患者心肌梗死后预防缺血事件。
J Am Coll Cardiol. 2016 Jun 14;67(23):2719-2728. doi: 10.1016/j.jacc.2016.03.524. Epub 2016 Apr 1.
6
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.替格瑞洛在既往经皮冠状动脉介入治疗史的糖尿病合并稳定型冠状动脉疾病患者中的应用（THEMIS-PCI）：一项 3 期、安慰剂对照、随机临床试验。
Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1.
7
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.替格瑞洛在既往心肌梗死的糖尿病患者中的缺血事件减少：PEGASUS-TIMI 54 研究。
J Am Coll Cardiol. 2016 Jun 14;67(23):2732-2740. doi: 10.1016/j.jacc.2016.03.529. Epub 2016 Apr 1.
8
Long-term use of ticagrelor in patients with prior myocardial infarction.既往心肌梗死患者中长期使用替格瑞洛。
N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.
9
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.接受普拉格雷或替格瑞洛治疗的急性冠脉综合征患者中长程与短程双联抗血小板治疗与冠状动脉血运重建：来自 RENAMI 注册研究的结果。
Eur J Prev Cardiol. 2020 May;27(7):696-705. doi: 10.1177/2047487319836327. Epub 2019 Mar 12.
10
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.替格瑞洛联合阿司匹林在急性冠状动脉综合征中的获益与风险：随机 GLOBAL LEADERS 试验的事后分析。
JAMA Cardiol. 2019 Nov 1;4(11):1092-1101. doi: 10.1001/jamacardio.2019.3355.
本文引用的文献
1
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.预测因素、类型和出血对既往心肌梗死稳定患者长期使用替格瑞洛净临床获益的影响。
J Am Heart Assoc. 2021 Feb 16;10(4):e017008. doi: 10.1161/JAHA.120.017008. Epub 2021 Feb 9.
2
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.替卡格雷与阿司匹林或阿司匹林单用在急性缺血性卒中和 TIA。
N Engl J Med. 2020 Jul 16;383(3):207-217. doi: 10.1056/NEJMoa1916870.
3
Monotherapy with a P2Y inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis.在已患有动脉粥样硬化的患者中，使用 P2Y 抑制剂或阿司匹林进行单一疗法的二级预防：系统评价和荟萃分析。
Lancet. 2020 May 9;395(10235):1487-1495. doi: 10.1016/S0140-6736(20)30315-9.
4
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.替格瑞洛联合或不联合阿司匹林用于 PCI 术后高危患者。
N Engl J Med. 2019 Nov 21;381(21):2032-2042. doi: 10.1056/NEJMoa1908419. Epub 2019 Sep 26.
5
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.替格瑞洛在稳定型冠心病合并糖尿病患者中的应用。
N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1.
6
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.定义行经皮冠状动脉介入治疗患者的高出血风险。
Circulation. 2019 Jul 16;140(3):240-261. doi: 10.1161/CIRCULATIONAHA.119.040167. Epub 2019 May 22.
7
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.双联抗血小板治疗的持续时间基于冠状动脉支架置入术后的缺血和出血风险。
J Am Coll Cardiol. 2019 Feb 26;73(7):741-754. doi: 10.1016/j.jacc.2018.11.048.
8
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention.阿司匹林-free 策略在心脑血管疾病和心源性卒中预防中的应用。
Nat Rev Cardiol. 2018 Aug;15(8):480-496. doi: 10.1038/s41569-018-0049-1.
9
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.经支架植入和随后双联抗血小板治疗（PRECISE-DAPT）的患者预测出血并发症的预测评分的推导和验证：来自临床试验的个体患者数据集的汇总分析。
Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5.
10
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.替卡格雷与氯吡格雷在有症状外周动脉疾病中的比较。
N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.
Zotero 插件